EveryLife Foundation Submits Comments on PDUFA VIII Reauthorization August 18, 2025 Share this page After compiling community input for the reauthorization of the Prescription Drug User Fee Act (PDUFA VIII), the EveryLife Foundation submitted comments reflecting our coalition’s shared priorities Legislative Proposals Patient-Focused Drug Development (PFDD) Rare Disease Innovation Hub Accelerated Approval FDA User Fees Related Articles Breaking News: The FDA has released the draft goals letter for PDUFA VIII August 13, 2026 The EveryLife Foundation Submits Comments to Support Patient-Focused Drug Development and Medical Innovation July 01, 2026 The EveryLife Foundation Submits Comments in Response to Rep. Auchincloss' Request July 01, 2026 See All News